Lynn D. Kramer

19.8k citations
65 papers · 5.4k · 5 hit papers · h-index 21

Impact in

Papers in

Lynn D. Kramer

61 papers receiving 5.3k citations

Lynn D. Kramer's Hit Papers

Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease 2024 · 78 citations
780+1+3Years since publication10002.0k3.0k

Peers

Lynn D. Kramer
Comparison fields: 5 of 132
  • Psychiatry and Mental health 1.8k
  • Biological Psychiatry 265
  • Physiology 2.0k
  • Neurology 592
  • Pharmacology 643
Replace Hans Basun with:
Hans Basun Sweden
Shobha Dhadda United States
Michelle Gee United Kingdom
Wei Qiao Qiu United States
John M. Ringman United States
Anton P. Porsteinsson United States
Christiane Reitz United States
Larisa Reyderman United States
Kwasi G. Mawuenyega United States
Madhav Thambisetty United States
Lynn D. Kramer relative to Hans Basun Sweden Hans Basun's profile →
Citations per field
00.5×8.0×
Hans Basun · 1×
Citations per year

Countries citing papers authored by Lynn D. Kramer

Since Specialization
Citations

This map shows the geographic impact of Lynn D. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn D. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn D. Kramer more than expected).

Fields of papers citing papers by Lynn D. Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn D. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn D. Kramer. The network helps show where Lynn D. Kramer may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynn D. Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynn D. Kramer Line = papers co-authored together Lynn D. Kramer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lecanemab in Early Alzheimer’s Disease
Hit paper breakdown →
20223045
2
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
Hit paper breakdown →
2021610
3 1996206
4 2013205
5
Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
Hit paper breakdown →
2022199
6 1992169
7
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease
Hit paper breakdown →
2022148
8 201382
9
Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
Hit paper breakdown →
202478
10 202372
11 199058
12 201450
13 199148
14 201532
15 202429
16 202228
17 199028
18 198727
19 201824
20 197823

About Lynn D. Kramer

Lynn D. Kramer is a scholar working on Physiology, Psychiatry and Mental health, Computational Theory and Mathematics, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 65 papers that have together received 5.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (22 papers), Epilepsy research and treatment (10 papers), Computational Drug Discovery Methods (9 papers), Dementia and Cognitive Impairment Research (9 papers), Statistical Methods in Clinical Trials (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and 14-3-3 protein interactions (3 papers). The work is most often cited by research in Psychiatry and Mental health (1.8k citations), Biological Psychiatry (265 citations), Physiology (2.0k citations), Neurology (592 citations) and Pharmacology (643 citations). Lynn D. Kramer has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Shobha Dhadda, Chad J. Swanson, Larisa Reyderman, Michael C. Irizarry, Michio Kanekiyo, Randall J. Bateman, Paul Aisen, Michelle Gee, Marwan Sabbagh and Christopher H. van Dyck. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Epilepsia, Annals of Neurology and Alzheimer s Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact